PT  - JOURNAL ARTICLE
AU  - Mathews, Manu
AU  - Muzina, David J.
TI  - Atypical antipsychotics: New drugs, new challenges
DP  - 2007 Aug 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 597--606
VI  - 74
IP  - 8
4099  - http://www.ccjm.org/content/74/8/597.short
4100  - http://www.ccjm.org/content/74/8/597.full
SO  - Cleve Clin J Med2007 Aug 01; 74
AB  - Compared with the first-generation, or “typical” antipsychotic drugs, second-generation or atypical antipsychotics cause fewer extrapyramidal (motor) problems, but they pose new challenges, as they often contribute to metabolic disturbances such as weight gain, hyperlipidemia, insulin resistance, and type 2 diabetes mellitus. Patients taking atypical antipsychotics should be monitored for glycemic and cardiovascular risk factors and should receive treatment for such problems as they arise.